We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

228 hedge funds and large institutions have $5.13B invested in Loxo Oncology, Inc in 2018 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 93 increasing their positions, 68 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 24

71% more call options, than puts

Call options by funds: $36.8M | Put options by funds: $21.6M

37% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 68

7% more funds holding

Funds holding: 213 → 228 (+15)

0% more capital invested

Capital invested by funds: $5.11B → $5.13B (+$19.3M)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
228
Holders Change
+15
Holders Change %
+7.04%
% of All Funds
5.21%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
41
Increased
93
Reduced
68
Closed
24
Calls
$36.8M
Puts
$21.6M
Net Calls
+$15.2M
Net Calls Change
-$2.31M

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$48.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$47.3M
3
CTA
Carillon Tower Advisers
Florida
+$43M
4
Alkeon Capital Management
Alkeon Capital Management
New York
+$33.7M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$33.1M

Top Sellers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
-$235M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$65.6M
3
O
OrbiMed
New York
-$35M
4
Sands Capital Management
Sands Capital Management
Virginia
-$27.5M
5
MWNA
Marshall Wace North America
New York
-$25.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
CTA
26
Carillon Tower Advisers
Florida
$43.8M +$43M +256,146 New
EAM
27
Eventide Asset Management
Massachusetts
$39.1M – – –
Ameriprise
28
Ameriprise
Minnesota
$38.2M +$761K +4,526 +2%
Charles Schwab
29
Charles Schwab
California
$35.3M +$13.1M +77,762 +60%
Goldman Sachs
30
Goldman Sachs
New York
$35.2M -$5.23M -31,150 -13%
RSCM
31
Rock Springs Capital Management
Maryland
$34.7M -$14.6M -86,919 -30%
Alkeon Capital Management
32
Alkeon Capital Management
New York
$34.3M +$33.7M +200,600 New
Invesco
33
Invesco
Georgia
$32.3M +$14.5M +86,005 +84%
VOYA Investment Management
34
VOYA Investment Management
Georgia
$32.1M +$254K +1,512 +0.8%
Brown Advisory
35
Brown Advisory
Maryland
$29.9M +$18.8M +112,005 +178%
OM
36
Opaleye Management
Massachusetts
$29.9M – – –
DCM
37
DAFNA Capital Management
California
$29M +$1.85M +11,000 +7%
JP Morgan Chase
38
JP Morgan Chase
New York
$28.9M +$18.9M +112,366 +199%
PAMU
39
Pictet Asset Management (UK)
United Kingdom
$28.2M +$1.23M +7,318 +5%
UBS AM
40
UBS AM
Illinois
$27.7M -$3.42M -20,352 -11%
MWNA
41
Marshall Wace North America
New York
$26.5M -$25.7M -152,972 -50%
CS
42
Credit Suisse
Switzerland
$24.5M +$2.39M +14,227 +11%
CS
43
Candriam SCA
Luxembourg
$23.5M +$10.6M +63,300 +85%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$22.7M -$406K -2,414 -2%
HIM
45
Hillhouse Investment Management
Cayman Islands
$22.4M +$8.4M +50,000 +62%
Renaissance Technologies
46
Renaissance Technologies
New York
$22M +$11M +65,600 +104%
KBC Group
47
KBC Group
Belgium
$21.5M +$10.6M +63,122 +101%
EA
48
Emerald Advisers
Pennsylvania
$20.2M +$4.2M +25,020 +27%
EMFAT
49
Emerald Mutual Fund Advisers Trust
Pennsylvania
$18.7M +$4.65M +27,699 +34%
ACM
50
Aquilo Capital Management
California
$18.7M -$2.94M -17,500 -14%
1
2
3 4 5

LOXO Hedge Fund Activity: Q3 2018 in Review

228 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2018, worth a combined $5.13B — up 0.38% from $5.11B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new LOXO positions and 24 closed out — a net gain of 17 holders — while 93 added to existing stakes and 68 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $48.9M. The largest seller was Aisling Capital, cutting an estimated $235M.

  • 228 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2018, up from 213 in Q2 2018.
  • Funds reported $5.13B of Loxo Oncology, Inc stock for Q3 2018, up 0.38% quarter-over-quarter.
  • 41 funds opened new Loxo Oncology, Inc positions in Q3 2018 and 24 closed out, a net change of +17 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2018 was Eagle Asset Management, an estimated $48.9M added.
  • The largest Loxo Oncology, Inc seller in Q3 2018 was Aisling Capital, an estimated $235M sold.

Based on aggregated 13F filings for Q3 2018.